Virginia Drug Discovery Consortium

VirginiaDrugDiscoveryRx: A Symposium on Academic-Industrial Partnerships in Drug Discovery

June 25 – 26, 2018

Founders Hall, George Mason University

Register NowPoster SubmissionSponsorship OpportunitiesLodgingProgramProgram


A symposium themed “Building Drug Discovery Partnerships”

featuring presentations by successful entrepreneurs who have translated basic research into biotech companies, by university researchers who have promising drug candidates in development, and by industry and government leaders

Who should attend?
  • Scientists with drug discovery related research
  • Investors looking for promising new drug start-up companies
  • Pharmaceutical and Biotech companies looking for new leads


This meeting is hosted by the Virginia Drug Discovery Consortium and VirginiaBio


Our Sponsors






VirginiaDrugDiscoveryRx: A Symposium on Academic-Industrial Partnerships in Drug Discovery

Some Program Highlights:

  • Keynote 1: Michael Weingarten (NIH, Head of NCI Development Center) “NCI’s multi-faceted Support for Early Stage Biotechnology Innovation”
  • Keynote 2: Jeff Gallagher (Virginia Bio) “An overview of biotech/pharma businesses in VA”
  • Keynote 3: Dan Paone (Glaxo SmithKline) “Characteristics of successful academic-pharma partnerships”
  • Invited Lecture: Umesh Desai (Virginia Commonwealth University) “A Synthetic, Highly Potent Allosteric Inhibitor of Human Factor Xla for Prothrombotic Disorders”
  • Invited Lecture: Elizabeth Sharlow (KeViRx and University of Virginia) “Targeting an undrugged phosphatase with JMS-053”
  • Invited Lecture: Webster Santos (Virginia Tech) “Controlling sphingosine-1-phosphate levels as a therapeutic strategy”
  • Invited Lecture: Barney Bishop (George Mason University) “Novel Antimicrobial Peptides from Extreme Species”
  • Panel Discussions: “What is pharma looking for in drug discovery, what sort of partnerships work best, what are new modalities for collaboration?”  “How to get your drug through clinical trials”  “Entrepreneurship”
  • Poster sessions to present research to colleagues and pharma


VirginiaCancerRx in the News!

John Lazo (VaDDC, Univ. of Virginia Pharmacology), David Kingston (VaDDC, Virginia Tech Chemistry) and Thomas Loughran (Director, Univ. of Virginia Cancer Center) were interviewed by Charlottesville’s CBS affiliate regarding Virginia Drug Discovery Consortium’s 2017...

read more


Virginia Tech
Virginia Biosciences Health Research Corporation

Want to work with us?

If you are interested in supporting this initiative, please contact us.